glp 1 agonist uses GLP-1 Receptor Shortage: Challenges and Solutions in Type 2 Diabetes Care How to use GLP-1 receptor
Description
E., & Jordan, J
Foundayo is a weight management drug
GLP-1 receptor agonists, offering clinically proven and durable weight-loss outcomes, are thus positioned to capture expanding demand in obesity management, driving market growth globally and complementing their use in diabetes care
N Engl J Med 6 392(10):958971 [DOI] [PubMed] 25.Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, Ma X, Mather KJ, Haupt A, Robins D, Pratt E, Kazda C, Konig M
